These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 27508020)
1. Targeting Btk with ibrutinib inhibit gastric carcinoma cells growth. Wang JD; Chen XY; Ji KW; Tao F Am J Transl Res; 2016; 8(7):3003-12. PubMed ID: 27508020 [TBL] [Abstract][Full Text] [Related]
2. Targeting Btk/Etk of prostate cancer cells by a novel dual inhibitor. Guo W; Liu R; Bhardwaj G; Yang JC; Changou C; Ma AH; Mazloom A; Chintapalli S; Xiao K; Xiao W; Kumaresan P; Sanchez E; Yeh CT; Evans CP; Patterson R; Lam KS; Kung HJ Cell Death Dis; 2014 Sep; 5(9):e1409. PubMed ID: 25188519 [TBL] [Abstract][Full Text] [Related]
3. Role of Bruton's tyrosine kinase in B cells and malignancies. Pal Singh S; Dammeijer F; Hendriks RW Mol Cancer; 2018 Feb; 17(1):57. PubMed ID: 29455639 [TBL] [Abstract][Full Text] [Related]
4. Pre-clinical anti-tumor activity of Bruton's Tyrosine Kinase inhibitor in Hodgkin's Lymphoma cellular and subcutaneous tumor model. Muqbil I; Chaker M; Aboukameel A; Mohammad RM; Azmi AS; Ramchandren R Heliyon; 2019 Aug; 5(8):e02290. PubMed ID: 31508518 [TBL] [Abstract][Full Text] [Related]
5. The effect of Bruton's tyrosine kinase (BTK) inhibitors on collagen-induced platelet aggregation, BTK, and tyrosine kinase expressed in hepatocellular carcinoma (TEC). Chen J; Kinoshita T; Gururaja T; Sukbuntherng J; James D; Lu D; Whang J; Versele M; Chang BY Eur J Haematol; 2018 Jul; ():. PubMed ID: 30030853 [TBL] [Abstract][Full Text] [Related]
13. Biochemical characterization of tirabrutinib and other irreversible inhibitors of Bruton's tyrosine kinase reveals differences in on - and off - target inhibition. Liclican A; Serafini L; Xing W; Czerwieniec G; Steiner B; Wang T; Brendza KM; Lutz JD; Keegan KS; Ray AS; Schultz BE; Sakowicz R; Feng JY Biochim Biophys Acta Gen Subj; 2020 Apr; 1864(4):129531. PubMed ID: 31953125 [TBL] [Abstract][Full Text] [Related]
14. Ibrutinib Inhibits BTK Signaling in Tumor-Infiltrated B Cells and Amplifies Antitumor Immunity by PD-1 Checkpoint Blockade for Metastatic Prostate Cancer. Deng G; He J; Huang Q; Li T; Huang Z; Gao S; Xu J; Wang T; Di J Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190284 [TBL] [Abstract][Full Text] [Related]
15. The mTOR kinase inhibitor everolimus synergistically enhances the anti-tumor effect of the Bruton's tyrosine kinase (BTK) inhibitor PLS-123 on Mantle cell lymphoma. Li J; Wang X; Xie Y; Ying Z; Liu W; Ping L; Zhang C; Pan Z; Ding N; Song Y; Zhu J Int J Cancer; 2018 Jan; 142(1):202-213. PubMed ID: 28905990 [TBL] [Abstract][Full Text] [Related]
16. Molecular characterization and function analysis of grouper (Epinephelus coioides) Bruton's tyrosine kinase BTK. Mo ZQ; Han Q; Zeng YL; Wang JL; Li XZ; Li YW; Sun HY; Li AX; Luo XC; Dan XM Fish Shellfish Immunol; 2018 Jun; 77():91-99. PubMed ID: 29567142 [TBL] [Abstract][Full Text] [Related]
17. Bruton's Tyrosine Kinase and Its Isoforms in Cancer. Wang X; Kokabee L; Kokabee M; Conklin DS Front Cell Dev Biol; 2021; 9():668996. PubMed ID: 34307353 [TBL] [Abstract][Full Text] [Related]
18. Dual functions of Bruton's tyrosine kinase and Tec kinase during Fcgamma receptor-induced signaling and phagocytosis. Jongstra-Bilen J; Puig Cano A; Hasija M; Xiao H; Smith CI; Cybulsky MI J Immunol; 2008 Jul; 181(1):288-98. PubMed ID: 18566394 [TBL] [Abstract][Full Text] [Related]
19. The role of PIM1 in the ibrutinib-resistant ABC subtype of diffuse large B-cell lymphoma. Kuo HP; Ezell SA; Hsieh S; Schweighofer KJ; Cheung LW; Wu S; Apatira M; Sirisawad M; Eckert K; Liang Y; Hsu J; Chen CT; Beaupre D; Chang BY Am J Cancer Res; 2016; 6(11):2489-2501. PubMed ID: 27904766 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of Bruton's tyrosine kinase and IL-2 inducible T-cell kinase suppresses both neutrophilic and eosinophilic airway inflammation in a cockroach allergen extract-induced mixed granulocytic mouse model of asthma using preventative and therapeutic strategy. Nadeem A; Ahmad SF; Al-Harbi NO; Ibrahim KE; Siddiqui N; Al-Harbi MM; Attia SM; Bakheet SA Pharmacol Res; 2019 Oct; 148():104441. PubMed ID: 31505252 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]